| Literature DB >> 20675137 |
Anthony J Sampognaro1, Mark D Wittman, Joan M Carboni, Chiehying Chang, Ann F Greer, Warren W Hurlburt, John S Sack, Dolatrai M Vyas.
Abstract
Pyrrolidine, pyrrolidinone, carbocyclic, and acyclic groups were used as isosteric proline replacements in a series of insulin-like growth factor I receptor kinase/insulin receptor kinase inhibitors. Examples that were similar in potency to proline-containing reference compounds were shown to project a key fluoropyridine amide into a common space, while less potent compounds were not able to do so for reasons of stereochemistry or structural rigidity. Copyright 2010 Elsevier Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20675137 DOI: 10.1016/j.bmcl.2010.07.045
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823